No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Child
-
Diuresis
-
Evidence-Based Medicine / organization & administration*
-
Humans
-
Medical Oncology / methods
-
Pediatrics / methods
-
Practice Guidelines as Topic
-
Renal Dialysis
-
Renal Insufficiency / complications*
-
Renal Insufficiency / therapy
-
Risk Factors
-
Salts / chemistry
-
Tumor Lysis Syndrome / etiology
-
Tumor Lysis Syndrome / prevention & control
-
Tumor Lysis Syndrome / therapy
-
Urate Oxidase / pharmacology
Substances
-
Antineoplastic Agents
-
Salts
-
rasburicase
-
Urate Oxidase